Biopharma Webinar
Accelerating Clinical Trials With Methylation-Based ctDNA Detection for Precise MRD and Response Monitoring
Register to Access Webinar:
Summary
Learn from biopharma industry leaders about how methylation-based circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) and response monitoring can enhance patient enrollment, provide early insights to therapy response, and expedite study evaluation to accelerate clinical trials.
Duration: 62 minutes